Clinical Trial Update: Memory Improvement Through Nicotine Dosing (MIND) Study [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating memory improvement through nicotine dosing in mild cognitive impairment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• Nicotine (nicotine)

Snippet

Sponsor: University of Southern California | Conditions: Mild Cognitive Impairment | Phase 2 | Status: COMPLETED